Advertisement

Safety of influenza vaccination during pregnancy

      Objective

      The purpose of this study was to evaluate the safety of influenza vaccine that is administered in the second or third trimester of gestation.

      Study design

      A retrospective electronic database search of 5 influenza seasons (July 1, 1998, to June 30, 2003) was performed at a large multispecialty clinic in Houston, Texas. Immunization rates were calculated, and outcomes of pregnancy were compared between a cohort of healthy women who received influenza vaccine and a control group of healthy unvaccinated women who were matched by age, month of delivery, and type of medical insurance.

      Results

      Among 7183 eligible mother-infant pairs, only 252 pregnant women (3.5%) received the influenza vaccine. Women with medical insurance were more likely to be vaccinated, although the rates for women with chronic underlying conditions were similar to those of healthy women, regardless of insurance status. The mean gestational age at the time of influenza vaccination was 26.1 weeks (range, 14-39 weeks). No serious adverse events occurred within 42 days of vaccination, and there was no difference between the groups in the outcomes of pregnancy (including cesarean delivery and premature delivery) and infant medical conditions from birth to 6 months of age.

      Conclusion

      Influenza vaccine that was administered in the second or third trimester of gestation was safe in this study population.

      Key words

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Centers for Disease Control and Prevention
        Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices [ACIP].
        MMRW Morb Mortal Wkly Rep. 2004; 53: 1-40
        • Shahab S.Z.
        • Glezen W.P.
        Influenza virus.
        in: Gonik B. Viral diseases in pregnancy. Springer-Verlag, New York1994: 215-223
        • Neuzil K.M.
        • Reed G.W.
        • Mitchel E.F.
        • Simonsen L.
        • Griffin M.R.
        Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women.
        Am J Epidemiol. 1998; 148: 1094-1102
        • Harris J.W.
        Influenza occurring in pregnant women: a statistical study of thirteen hundred and fifty cases.
        JAMA. 1919; 72: 978-980
        • Freeman D.W.
        • Barno A.
        Deaths from Asian influenza associated with pregnancy.
        Am J Obstet Gynecol. 1959; 78: 1172-1175
      1. Centers for Disease Control and Prevention. Guidelines for vaccinating pregnant women. Updated October 2003. Available at: www.cdc.gov/nip/publications/preg_guide.htm.

      2. Centers for Disease Control and Prevention. 2002 National health interview survey. Available at: www.cdc.gov/nchs.

        • Heinonen O.P.
        • Slone D.
        • Shapiro S.
        Immunizing agents.
        in: Kaufman D.W. Birth defects and drugs in pregnancy. Publishing Sciences Group, Littleton (MA)1977: 314-321
        • Sumaya C.V.
        • Gibbs R.S.
        Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant.
        J Infect Dis. 1979; 140: 141-146
        • Murray D.L.
        • Imagawa D.T.
        • Okada D.M.
        • St. Geme J.W.
        Antibody response to monovalent A/New Jersey/8/76 influenza vaccine in pregnant women.
        J Clin Microbiol. 1979; 10: 184-187
        • Deinhard A.S.
        • Ogburn Jr., P.
        A/NJ/8/76 influenza vaccination program: effects on maternal health and pregnancy outcome.
        Am J Obstet Gynecol. 1981; 140: 240-245
        • Englund J.A.
        • Mbawuike I.N.
        • Hammill H.
        • Holleman M.C.
        • Baxter B.D.
        • Glezen P.
        Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants.
        J Infect Dis. 1993; 168: 647-656
        • Neuzil K.M.
        • Mellen B.G.
        • Wright P.F.
        • Mitchel E.F.
        • Griffin M.R.
        The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children.
        N Engl J Med. 2000; 342: 225-231
        • Hartert T.V.
        • Neuzil K.M.
        • Shintani A.K.
        • Mitchel Jr., E.F.
        • Snowden M.S.
        • Wood L.B.
        • et al.
        Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season.
        Am J Obstet Gynecol. 2003; 189: 1705-1712

      Linked Article

      • Safety of influenza vaccination during pregnancy
        American Journal of Obstetrics & GynecologyVol. 194Issue 4
        • Preview
          To the Editors: We read with interest the study by Munoz et al,1 which compared pregnancy outcomes between 252 women vaccinated with inactivated influenza vaccines (IIV) and 826 matched unvaccinated controls. The authors concluded that IIV is safe when administered in the second or third trimester of gestation; however, they acknowledge that the study population was relatively small.
        • Full-Text
        • PDF